Vaidyanathan G - Search Results

1

Low-level whole-brain radiation enhances theranostic potential of single-domain antibody fragments for human epidermal growth factor receptor type 2 (HER2)-positive brain metastases.

Procissi D, Jannetti SA, Zannikou M, Zhou Z, McDougald D, Kanojia D, Zhang H, Burdett K, Vaidyanathan G, Zalutsky MR, Balyasnikova IV. Procissi D, et al. Among authors: vaidyanathan g. Neurooncol Adv. 2022 Aug 23;4(1):vdac135. doi: 10.1093/noajnl/vdac135. eCollection 2022 Jan-Dec. Neurooncol Adv. 2022. PMID: 36128586 Free PMC article.

2

1-(m-[211At]astatobenzyl)guanidine: synthesis via astato demetalation and preliminary in vitro and in vivo evaluation.

Vaidyanathan G, Zalutsky MR. Vaidyanathan G, et al. Bioconjug Chem. 1992 Nov-Dec;3(6):499-503. doi: 10.1021/bc00018a006. Bioconjug Chem. 1992. PMID: 1463779

3

Labeling proteins with fluorine-18 using N-succinimidyl 4-[18F]fluorobenzoate.

Vaidyanathan G, Zalutsky MR. Vaidyanathan G, et al. Int J Rad Appl Instrum B. 1992 Apr;19(3):275-81. doi: 10.1016/0883-2897(92)90111-b. Int J Rad Appl Instrum B. 1992. PMID: 1629016

4

Fluorine-18-labeled monoclonal antibody fragments: a potential approach for combining radioimmunoscintigraphy and positron emission tomography.

Vaidyanathan G, Bigner DD, Zalutsky MR. Vaidyanathan G, et al. J Nucl Med. 1992 Aug;33(8):1535-41. J Nucl Med. 1992. PMID: 1634947 Free article.

5

Protein radiohalogenation: observations on the design of N-succinimidyl ester acylation agents.

Vaidyanathan G, Zalutsky MR. Vaidyanathan G, et al. Bioconjug Chem. 1990 Jul-Aug;1(4):269-73. doi: 10.1021/bc00004a007. Bioconjug Chem. 1990. PMID: 2096920

6

Radioiodination of antibodies via N-succinimidyl 2,4-dimethoxy-3-(trialkylstannyl)benzoates.

Vaidyanathan G, Zalutsky MR. Vaidyanathan G, et al. Bioconjug Chem. 1990 Nov-Dec;1(6):387-93. doi: 10.1021/bc00006a004. Bioconjug Chem. 1990. PMID: 2099187

7

Tumor-specific anti-epidermal growth factor receptor variant III monoclonal antibodies: use of the tyramine-cellobiose radioiodination method enhances cellular retention and uptake in tumor xenografts.

Reist CJ, Archer GE, Kurpad SN, Wikstrand CJ, Vaidyanathan G, Willingham MC, Moscatello DK, Wong AJ, Bigner DD, Zalutsky MR. Reist CJ, et al. Among authors: vaidyanathan g. Cancer Res. 1995 Oct 1;55(19):4375-82. Cancer Res. 1995. PMID: 7671250

8

Validation of 4-[fluorine-18]fluoro-3-iodobenzylguanidine as a positron-emitting analog of MIBG.

Vaidyanathan G, Affleck DJ, Zalutsky MR. Vaidyanathan G, et al. J Nucl Med. 1995 Apr;36(4):644-50. J Nucl Med. 1995. PMID: 7699460 Free article.

9

Uptake mechanisms of meta-[123I]iodobenzylguanidine in isolated rat heart.

Degrado TR, Zalutsky MR, Vaidyanathan G. Degrado TR, et al. Among authors: vaidyanathan g. Nucl Med Biol. 1995 Jan;22(1):1-12. doi: 10.1016/0969-8051(94)00084-w. Nucl Med Biol. 1995. PMID: 7735158

10

Quantitation of 211At in small volumes for evaluation of targeted radiotherapy in animal models.

Johnson EL, Turkington TG, Jaszczak RJ, Gilland DR, Vaidyanathan G, Greer KL, Coleman RE, Zalutsky MR. Johnson EL, et al. Among authors: vaidyanathan g. Nucl Med Biol. 1995 Jan;22(1):45-54. doi: 10.1016/0969-8051(94)00077-w. Nucl Med Biol. 1995. PMID: 7735169

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

189 results

Search Page

Filters